ArticleFrontiers in oncology2022

Long-Term Results of a Phase 2 Study of Definitive Chemoradiation Therapy Using S-1 for Esophageal Squamous Cell Carcinoma Patients Who Were Elderly or With Serious Comorbidities.

Yun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.